<?xml version="1.0" encoding="UTF-8"?>
<p id="p0155">DISCOVERY (NCT04315948) – a multi-centre, adaptive, randomized, open label clinical trial to assess the safety and efficacy of treatments of COVID-19 in hospitalized adults, was initiated by the French Institut National de la Santé Et de la Recherche Médicale (INSERM) as the European counterpart of the SOLIDARITY trial, with the same treatment regimen. The study will be conducted on 3100 patients in seven countries across Europe 
 <xref rid="b0445" ref-type="bibr">[89]</xref>.
</p>
